학술논문
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 phase 3 randomized controlled clinical trial
Document Type
Article
Author
Source
In: Journal fur Neurologie, Neurochirurgie und Psychiatrie . (Journal fur Neurologie, Neurochirurgie und Psychiatrie, 2019, 20(2):80-81)
Subject
Language
English
German
German
ISSN
16809440
16081587
16081587